Tolcapone in Obsessive Compulsive Disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial

被引：0
|
作者：
Grant, Jon [1 ]
Chamberlain, Samuel [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2021年 / 46卷 / SUPPL 1期
关键词：
COMT Inhibitor; Obsessive-Compulsive Disorder (OCD); Pharmacotherapy;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P443
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [1] Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial
    Grant, Jon E.
    Hook, Roxanne
    Valle, Stephanie
    Chesivoir, Eve
    Chamberlain, Samuel R.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (05) : 225 - 229
  • [2] A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder
    Hollander, E
    Kaplan, A
    Stahl, SM
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2003, 4 (01): : 30 - 34
  • [3] Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
    Afshar, Hamid
    Akuchekian, Shahla
    Mahaky, Behzad
    Zarean, Elham
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (10): : 976 - 981
  • [4] Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial
    Farnia, Vahid
    Gharehbaghi, Haniyeh
    Alikhani, Mostafa
    Almasi, Afshin
    Golshani, Sanobar
    Tatari, Faeze
    Davarinejad, Omran
    Salemi, Safora
    Bahmani, Dena Sadeghi
    Holsboer-Trachsler, Edith
    Brand, Serge
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 104 : 137 - 143
  • [5] Gamma Ventral Capsulotomy for Obsessive Compulsive Disorder: A Placebo-Controlled, Double-Blind Clinical Trial
    Lopes, Antonio C.
    Batistuzzo, Marcelo C.
    Canteras, Miguel M.
    Joaquim, Marines A.
    de Mathis, Maria E.
    Hoexter, Marcelo Q.
    Greenberg, Benjamin D.
    Noren, Georg
    Rasmussen, Steven A.
    Shavitt, Roseli G.
    Miguel, Euripedes C.
    [J]. BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 33S - 33S
  • [6] Treatment of obsessive-compulsive disorder with fluvoxamine: A multicentre, double-blind, placebo-controlled trial
    Goodman, WK
    Kozak, MJ
    Liebowitz, M
    White, KL
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 (01) : 21 - 29
  • [7] Double-blind, placebo-controlled trial of topiramate augmentation in the treatment of obsessive-compulsive disorder
    Berlin, Heather A.
    Koran, Lorrin M.
    Jenike, Michael A.
    Shapira, Nathan A.
    Chaplin, William
    Pallanti, Stefano
    Hollander, Eric
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 170S - 170S
  • [8] OBSESSIVE-COMPULSIVE DISORDER - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CLOMIPRAMINE IN 27 PATIENTS
    JENIKE, MA
    BAER, L
    SUMMERGRAD, P
    WEILBURG, JB
    HOLLAND, A
    SEYMOUR, R
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1989, 146 (10): : 1328 - 1330
  • [9] Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder A Randomized, Double-Blind, Placebo-Controlled Trial
    Askari, Neda
    Moin, Mandieh
    Sanati, Mohammad
    Tajdini, Masih
    Hosseini, Seyed-Mohammad-Reza
    Modabbernia, Amirhossein
    Najand, Babak
    Salimi, Samrand
    Tabrizi, Mina
    Ashrafi, Mandana
    Hajiaghaee, Reza
    Akhondzadehl, Shahin
    [J]. CNS DRUGS, 2012, 26 (10) : 883 - 892
  • [10] Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial
    Shalbafan, M.
    Mohammadinejad, P.
    Shariat, S. -V.
    Alavi, K.
    Zeinoddini, A.
    Salehi, M.
    Askari, N.
    Akhondzadeh, S.
    [J]. PHARMACOPSYCHIATRY, 2015, 48 (4-5) : 136 - 140
12345